In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, Eris Lifesciences has informed that it enclosed the schedule of Analyst/ Institutional Investor Meeting. The schedule is indicative and is subject to changes necessitated by any unforeseen developments. No unpublished price sensitive information (UPSI) is intended to be discussed during the interaction.
The above information is a part of company’s filings submitted to BSE.
